AbbVie (NYSE:ABBV) Raised 2023 Adjusted Earnings Guidance
AbbVie(NYSE:ABBV) reported Q1 adjusted earnings of $2.46 per diluted share, compared with $3.16 a year earlier. Analysts polled by Capital IQ expected $2.48. Net revenue for the quarter ended March 31 was $12.23 billion, compared with $13.54 billion a year earlier. Analysts surveyed by Capital IQ expected $12.25 billion. The company raised its adjusted earnings guidance for full-year 2023 to $10.72 to $11.12 per diluted share from $10.62 to $11.02. Analysts polled by Capital IQ expect 2023 adjusted earnings of $10.95.
AbbVie (NYSE:ABBV) Raised 2023 Adjusted Earnings Guidance Read Post »